‘Strong concerns’: ACCC queries pathology merger bid The regulator has said a proposed takeover of Healius by ACL, a move opposed by the RACGP, could have an adverse effect on patients.
RACGP issues warning over pathology takeover bid A merger that would create Australia’s largest pathology business could be against the best interests of patients, the ACCC has been told.